Henoch-Schönlein purpura overview: Difference between revisions

Jump to navigation Jump to search
Luke Rusowicz-Orazem (talk | contribs)
No edit summary
Luke Rusowicz-Orazem (talk | contribs)
Line 5: Line 5:
== Overview ==
== Overview ==
In [[medicine]] ([[rheumatology]] and [[pediatrics]]) '''Henoch-Schönlein purpura''' (HSP, also known as ''allergic purpura'') is a systemic [[vasculitis]] (inflammation of blood vessels) characterized by deposition of [[immune complex]]es containing the antibody [[IgA]], especially in the skin and kidney. It occurs mainly in children. Typical symptoms include palpable [[purpura]] (small hemorrhages in the skin), [[arthralgia|joint pains]] and [[abdominal pain]]. Most cases are self-limiting and require no treatment apart from symptom control, but the disease may relapse (in 33% of cases) and cause irreversible kidney damage (in 1%).<ref name=Saulsbury2001>{{cite journal |author=Saulsbury FT |title=Henoch-Schönlein purpura |journal=Curr Opin Rheumatol |volume=13|issue=1 |pages=35–40 |year=2001 |pmid=11148713 |doi=}}</ref>
In [[medicine]] ([[rheumatology]] and [[pediatrics]]) '''Henoch-Schönlein purpura''' (HSP, also known as ''allergic purpura'') is a systemic [[vasculitis]] (inflammation of blood vessels) characterized by deposition of [[immune complex]]es containing the antibody [[IgA]], especially in the skin and kidney. It occurs mainly in children. Typical symptoms include palpable [[purpura]] (small hemorrhages in the skin), [[arthralgia|joint pains]] and [[abdominal pain]]. Most cases are self-limiting and require no treatment apart from symptom control, but the disease may relapse (in 33% of cases) and cause irreversible kidney damage (in 1%).<ref name=Saulsbury2001>{{cite journal |author=Saulsbury FT |title=Henoch-Schönlein purpura |journal=Curr Opin Rheumatol |volume=13|issue=1 |pages=35–40 |year=2001 |pmid=11148713 |doi=}}</ref>
==Historical Perspective==


==Historical Perspective==
==Historical Perspective==

Revision as of 18:27, 28 June 2016

Henoch-Schönlein purpura Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Henoch-Schönlein purpura from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Henoch-Schönlein purpura overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Henoch-Schönlein purpura overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Henoch-Schönlein purpura overview

CDC on Henoch-Schönlein purpura overview

Henoch-Schönlein purpura overview in the news

Blogs on Henoch-Schönlein purpura overview

Directions to Hospitals Treating Henoch-Schönlein purpura

Risk calculators and risk factors for Henoch-Schönlein purpura overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In medicine (rheumatology and pediatrics) Henoch-Schönlein purpura (HSP, also known as allergic purpura) is a systemic vasculitis (inflammation of blood vessels) characterized by deposition of immune complexes containing the antibody IgA, especially in the skin and kidney. It occurs mainly in children. Typical symptoms include palpable purpura (small hemorrhages in the skin), joint pains and abdominal pain. Most cases are self-limiting and require no treatment apart from symptom control, but the disease may relapse (in 33% of cases) and cause irreversible kidney damage (in 1%).[1]

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Henoch-Schönlein Purpura from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Surgery

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

References

  1. Saulsbury FT (2001). "Henoch-Schönlein purpura". Curr Opin Rheumatol. 13 (1): 35–40. PMID 11148713.

Template:WH Template:WS